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Background: The avian influenza virus (AIV) causes frequent disease with high morbidity and mortality. RNA
interference (RNAi) has been shown to provide an effective antiviral defense in animals, and several studies have
focused on harnessing small interfering RNAs (siRNAs) to inhibit viral infections. In addition, single chain variable
fragments (scFvs) contain the complete antigen binding site, and specific scFvs can bind to and neutralize viruses.
Results: Fourteen positive scFvs were selected by the yeast two-hybrid system. Using molecular docking technology,
we selected the three highest affinity scFvs for further functional validation. Results of indirect ELISA and IFA showed
that all three scFvs could bind to FJ13 strain and had neutralizing activity, decreasing the viral infectivity markedly.
Chicken fibroblastic DF-1 cells were transfected with scFvs in combination with siRNA-NP604 (an siRNA of anti-AIV
NP protein previously reported). Following infection with FJ13 virus, copy numbers of the virus were significantly
reduced from 12 h to at least 60 h post-infection compared to that achieved in cells transfected with scFv or
siRNA-NP604 separately.
Conclusions: A novel combination of antiviral siRNAs expressed in chicken cells and chicken antibody single-chain
variable fragments (scFvs) secreted from the cells has a synergistic inhibitory effect on the avian influenza viral
proliferation in vitro. Intracellular application of scFvs and anti-viral siRNA may provide a new approach to influenza
prevention and treatment.
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Avian influenza viruses (AIVs) are important pathogens
affecting the poultry industry worldwide, with some in-
fecting humans with a high fatality rate [1]. Due to the
diversity and propensity for inter-species transmission,
AIVs present a challenge for vaccine developers [2,3].
RNA interference (RNAi) has been shown to provide an
effective antiviral defense in animals, and several studies
have focused on harnessing small interfering RNAs (siR-
NAs) to inhibit viral infections [4-8]. An siRNA-based* Correspondence: weiquan8@cau.edu.cn
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unless otherwise stated.microbicide has been shown to protect mice from lethal
herpes simplex virus 2 infection or transmission [9], and
siRNAs specific for conserved regions of influenza virus
genes prevented and even treated influenza viral infec-
tion in mice [6]. In 2011, Lyall et al. [3] reported that
transgenic expression of an RNA hairpin molecule was
capable of inhibiting influenza viral polymerase activity
in the chicken.
ScFvs, another effective countermeasure against ani-
mal virus, are among the most widely used recombinant
antibodies (rAbs) as they have been successfully modi-
fied into a number of different Ab formats and are easily
expressed by several expression systems. Since they con-
tain the complete antigen binding site, specific scFvs cantd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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used a biopanning based approach to isolate a large
array of scFv clones against H5N1 virus from the human
semi-synthetic ETH-2 phage antibody library of which
two, AV.D1 and AV.C4, exerted a significant inhibition
of H5N1 virus infection. Additionally, a high-affinity hu-
man scFv antibody against the recombinant H5N1 virus
hemagglutinin ectodomain (HA1) showed satisfactory
antiviral effects against challenge with H5N1 viruses in
embryonated chicken eggs [14].
In the present study, we report that use of siRNA tar-
geting the NP protein, in combination with single chain
variable fragments (scFvs) of anti-HA protein antibody,
has a synergistic inhibitory effect on the propagation of
avian influenza virus H5N1. Two antiviral genes were
expressed in the DF-1 chicken fibroblast line such that
an siRNA was stably expressed in the cells in combin-
ation with scFvs that were continuously secreted into
the extracellular fluid. We show that the infectious titer
and copy number of virus particles were both signifi-
cantly reduced in infected cells.
Results
Selection of scFvs using the yeast two-hybrid (Y2H) method
Initially, high yields of chicken immunoglobulin VH and
VL gene fragments were obtained by PCR amplification.
The joining of VH and VL via a flexible peptide (Gly4-
Ser)3 linker sequence using overlap extension PCR
produced a pGADT7 scFv library. The library titer was
6.53×109 cfu/ml. Before the Y2H experiments, it was
first confirmed that pGBKT7-HA+pGADT7-BD and
pGADT7-ScFv+ pGBKT7-blank had no autoactivator
activity in yeast, and that growth of yeast cells did not
impact the expression of pGBKT7-HA. Following incu-
bation for 20 h to permit mating of pGBKT7-HA and
pGADT7-ScFv in YDPA/Kana+, the appearance of a clo-
verleaf structure formed by yeast clustering confirmed
that the mating was successful. Fourteen colonies posi-
tive for scFvs were identified by their blue color resulting
from X-gal staining of β-galactosidase activity (Figure 1).
Further screening of scFvs by computational prediction
We utilized computational methods to predict the poten-
tial binding affinities between these antibodies and the HA
protein. Three-dimensional structures of the HA protein
and scFvs were constructed by DiscoveryStudio software.
As can be seen in the Ramachandran plot, 95% of plots
that were surrounded by the red trace contour indicate
that the structures were highly reliable (Figure 2A). Binding
affinities between the 13 scFvs and an HA protein were
predicted by the ZDOCK module of the DiscoveryStudio
package. As shown in Table 1, the docking results were
graded and sorted in ascending order of binding energy.
The 3 lowest binding energies were shown by Nos. 1, 2and 6 which mean they had the highest affinities for the
HA protein. These three scFvs (named scFv1-3) were
chosen for the next functional tests. Docking results
showed that they bound to separate conformational epi-
topes (Figure 2B). The Y2H results showed good reprodu-
cibility and all were expressed in the mating yeast
(Figure 2C and D). The three sequences were all submitted
to GenBank [ID: FJ605117, FJ605118, FJ605119].
Expression of the three scFvs in DF-1 cells
Signal peptides and c-Myc Epitope Tag sequences were
respectively added to the 5′ and 3′ ends of the scFvs
through PCR primers (Table 2), and the modified scFvs
were inserted separately into pIRES2-EGFP vector. At
48 h following transfection of DF-1 cells with the
pIRES2-scFvs, the expression level of GFP was readily
observed by fluorescence microscopy (Figure 3A). Fol-
lowing the culture supernatants in each well were con-
centrated and western blotting showed that all three
scFvs were expressed (Figure 3B).
The binding activity of scFvs to FJ13 virus
The binding activity of scFvs to virus in cells was
assessed using indirect-ELISA and IFA. As tested by
ELISA, all 3 scFvs expressed by DF-1 bound to the
FJ13. The titer of scFv1 was slightly higher than the
others, but the difference was not statistically significant
(Figure 3C). The IFA used the three scFvs as the primary
antibodies. Results showed that all three exhibited virus
binding activity in MDCK cells. Titers of the scFvs at
1 μg/ml were equal to the anti-AIV H5N1 HA mAb at
1:300 (Figure 3D). Mixing virus with the scFvs 1 h before
infection of cells at 37°C significantly reduced its infect-
ivity (Figure 3E), indicating that all three scFvs had virus
neutralizing activity.
Effect of siRNA in combination with scFv1 against FJ13
virus in DF-1 cells
From the above results, scFv1 was selected to be co-
expressed with siRNA NP604 targeting the NP of FJ13 [15],
and DF-1 cells were stably transfected with the shRNA-
expression plasmid psiSTRIKE-NP604 (hereafter referred
to as NP604 cells). Expression of GFP in the NP604 cells
was observed by fluorescent microscopy 48 h following
transient transfection with pIRES2-scFv1 (Figure 4A). The
cell culture supernatant was concentrated and western
blots showed that the scFv1 was also expressed in the
NP604 cells (Figure 4B).
Infection of DF-1 and MDCK cells with FJ13 virus con-
firmed cytopathogenicity in DF-1 cells, with similar virus
titers (as cell culture ID50 assay, CCID50). The difference
in FJ13 virus growth kinetics in each cell line was evalu-
ated by qPCR. First, DF-1 and NP604 cells were transi-
ently transfected with pIRES2-ScFv1 (hereafter referred to
Figure 1 Yeast two-hybrid assay and chromogenic results. (A) Constructs used in the yeast two-hybrid assays for screening of specific scFvs
against HA protein. A cDNA library of scFvs was subcloned into a pGADT7 yeast two-hybrid prey vector for fusion to the GAL4 transactivation
domain (AD). (B) Screening for specific scFvs against HA. Yeast clones containing bait and prey vectors were selected on SD/-Leu/-Trp/-His/-Ade
plate. Fourteen positive scFv fragments appeared blue through X-gal staining.
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numbers of the viral genomic RNA were then determined
by qPCR every 12 h for 60 h in DF-1, NP604, scFv and
scFv-NP604 cells infected with FJ13 virus. As shown in
Figure 4C, although the growth of FJ13 in NP604 and scFv
cells was significantly lower than in DF-1 cells, it was con-
sistently slightly lower in the scFv-NP604 cells than in all
others. The results by CCID50 assay were similar to qPCR
(Figure 4D).
Discussion
ScFvs consist of VH and VL chains joined via a flexible
peptide linker. Their advantages are high antigen bind-
ing activity, expression efficiency, strong penetrability
and a short in vivo half-life [11]. The scFvs producted by
murine hybridoma cell lines are capable of binding tar-
get antigens with an affinity similar to that of the parent
mAb [16]. In addition, the single VH and VL region of
the chicken immunoglobulin gene simplifies building a
library, in contrast to that of mammals [17,18]. We gen-
erated VH and VL fragments from AIV H5N1 FJ13 im-
munized chickens. Assembly of VH, VL and linker
fragments by overlap extension PCR yielded a library
with a titer of 6.53×109 cfu/ml, high enough for the Y2H
screen.
For generating synthetic scFvs, several different mo-
lecular display formats have been described, including
phage-display, ribosome display and cell-surface display
[11]. The yeast two-hybrid system is a simple, cost-
effective technique to screen for the scFv library, and
antibodies synthesized in this system generally exhibit
good expression levels and specific binding activities in
eukaryotic cells [19]. In a comparative study using the
same immune scFv cDNA library, yeast display was
shown to sample the immune antibody repertoire con-
siderably more fully than phage display, selecting all the
scFv identified by phage display and twice as many novelantibodies [20]. However, Y2H library screening also
generates a significant number of false-positive interac-
tions, including “biological” false-positives: protein–pro-
tein interactions that occur in yeast cells, but do not
occur in vivo in the organism of study, and “technical”
false-positives: protein–protein interactions identified in
Y2H screens due to technical limitations of the system
[21]. It is very important, therefore, that a verification
test be conducted to confirm the specificity of scFvs
binding to the HA protein. The number of positive
clones screened by Y2H is too large and difficult to ver-
ify individually, and using bioinformatics software for
further screening greatly reduced the labor intensity. By
ZDOCK software analysis, we chose the three with low-
est HA binding energy from the 14 Y2H positive ones.
The results of functional verification indicated Y2H
combined with ZDOCK software analysis was reliable
and effective.
To detect the co-antiviral effect induced by siRNA in
combination with scFv1, NP-604 cells were transiently
transfected with the scFv1 expression plasmid. Virus ti-
ters in the culture supernatants of NP604 cells trans-
fected with scFv1 were reduced by 70-fold compared
with titers in NP604 cells or scFv1 cells alone at 60 h
post inoculation. Our study opens a new approach to in-
fluenza prevention and treatment by using scFv and
siRNA together. We predict this concept can also pro-
vide a basis for breeding transgenic AIV-resistant chick-
ens. As transgenic siRNAs would be stably expressed in
all body cells, they will be present to interfere with NP
synthesis and limit viral replication upon viral invasion.
Since scFvs are secreted into the blood after expression,
they will bind to the HA of circulating virus, thereby
preventing viral infection and spread. If they are effi-
ciently expressed, the result might be significant inhib-
ition of virus at the earliest stage of infection, before an
acquired immune response can be mounted.
Figure 2 Screening of scFvs by ZDOCK module of DiscoveryStudio software. (A) Homology modeling of HA protein and scFvs. (B) Molecular
docking between scFvs and HA protein. (C) The high-affinity scFvs were confirmed again by yeast two-hybrid assay. Chromogenic results showed
scFv1, scFv2 and scFv3 were all positive and the blank controls were negative. (D) Expression of HA and scFvs in yeast as detected by western blot.
Upper row: detection of HA expression by anti-Myc Epitope Tag.; Lower row: detection of scFvs expression by anti-HA Epitope Tag.
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Three scFvs binding to the HA protein of AIV FJ13 strain
with high affinity were selected by the yeast two-hybrid
system and molecular docking technology. A combination
of antiviral siRNAs expressed in chicken cells and chicken
antibody single-chain variable fragments (scFvs) secreted
from the cells has a synergistic inhibitory effect on virus
proliferation in vitro. Intracellular expression of scFvs and




Influenza A virus strain A/duck/Fujian/13/2002 (FJ13),
H5N1 subtype, was kindly provided by the late ProfessorHongwei Gao (Academy of Military Medical Sciences,
Changchun). The AIV was propagated in the allantoic
cavity of 10-day-old embryonated specific pathogen-free
(SPF) eggs. MDCK and DF-1 cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Gibco)
supplemented with 10% fetal bovine serum (FBS, Gibco)
at 37°C in 5% CO2 [22]. All experiments with H5N1
virus were conducted in a biosafety level 3 laboratory fa-
cility at the Changchun Institute of Veterinary Science.
Virus titration (cell culture ID50 assay, CCID50) was car-
ried out in 96-well microtitration plates (Costar) seeded
with MDCK cells (105 cells per well). Serial 10-fold virus
dilutions in DMEM (100 μl) were made in triplicate and
the plates were incubated in 5% CO2 at 37°C. Wells were
examined microscopically and endpoints were taken as
Table 1 Binding values of HA protien and positive scFvs
Top ordering Binding energy
1 -2.094395 0.294107 1.59388 3 178 135 19.82 2 -1 -1 -154.472
2 -0.733038 1.524811 -2.844718 8 29 206 21.7 26 6 -1 -149.158
6 -0.733038 0.997766 -2.693871 163 3 183 22.6 6 73 1 -137.171
5 -0.314159 0.632797 1.989858 201 185 47 20 2 -1 -1 -131.664
11 -1.570796 1.554776 0.100351 10 23 2 22.56 1 -1 -1 -118.933
3 -1.989675 0.934873 -2.010822 162 187 2 20.52 12 21 -1 -116.42
13 -0.523599 1.135813 -2.658866 178 9 174 19.24 1 -1 -1 -116.378
4 -0.733038 1.743328 0.663347 19 164 189 19.84 2 -1 -1 -116.115
7 -1.675516 0.65244 2.197129 8 33 178 19.38 3 -1 -1 -114.846
8 -0.837758 1.889815 2.70157 14 22 21 24.82 1 -1 -1 -111.05
14 1.832596 0.41964 2.974122 14 3 135 22 1 -1 -1 -110.35
9 -0.314159 0.869748 2.095969 183 159 16 23.3 2 20 1 -107.702
12 2.094395 1.736875 3.023612 4 39 183 19.78 1 -1 -1 -107.003
10 2.879793 1.184361 0.625864 19 21 0 18.7 1 17 -1 -82.9037
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were calculated by the Reed-Muench method.
Construction of scFv Libraries
Eight four-week-old SPF chickens were immunized by
four injections of formalin-inactivated FJ13 virus four
times, together with complete Freund’s adjuvant for the 1st
injection and incomplete adjuvant thereafter. The time
interval until the second injection was two weeks, and one
week for the others. Virus protein concentrations of theTable 2 Sequences of oligonucleotides used for
construction of libraries
















Synthetic linker used for overlap extension PCR shown underlined.
Restriction enzyme sites used for cloning shown in bold.
Signal peptide sequence and c-Myc epitope tag sequence shown italics.respective injections were 0.2 mg, 0.4 mg, 0.8 mg and 0.8
mg. Seven days later, the chickens were euthanized and
spleens were removed for total RNA extraction. Antibody
titers in serum from the wing vein were determined by the
hemagglutination-inhibition test.
Total RNA was extracted from homogenized spleens
with Trizol (Invitrogen, USA) (Figure 1A). Approximate
8 μg RNA was randomly primed in a total volume of
100 μl to produce complementary DNA (cDNA) using a
cDNA synthesis kit (Trans, China). The specific primers
were RT-VH or RT-VL (Table 2).
VH and VL chains were amplified using primers VH-
P1 &VH-P2 for the VH region or VL-P1 & VL-P2 for
the VL region (Table 2). Gel-purified VH and VL chains
were connected via a synthetic linker (Table 2) using
overlap extension PCR. After 16 rounds of amplification
(94°C for 1 min, 45°C for 1 min and 72°C for 1 min), 2
μl of each primer VHp1-NdeIand VLp2-BamHI (Table 2)
were added and an additional 14 cycles was performed.
The scFv genes were ligated with the pGADT7 vector
((kindly provided by Xing-Feng Liu Ph.D. of Tsinghua
University).
Yeast two-hybrid method for scFvs selection
The HA protein of FJ13 was used as bait protein to test
the pGADT7-scFv library in a yeast two-hybrid (Y2H)
screen. Plasmid pGBKT7-HA was prepared by cloning
RT- PCR fragments of the FJ13 virus genome RNA into
pGBKT7 vector. The AH109 yeast strain was co-
transfected with the bait construct and empty pGADT7
vector to test and exclude auto-activation of reporter
genes. After verification, the Y187 yeast strain was trans-
fected with pGBKT7-HA. The Y2H screen was performed
Figure 3 Verification of the binding activity of scFvs expressed by DF-1 to FJ13 virus. (A) Transient expression of scFvs in serum-free
cultured DF-1 cells indirectly detected by EGFP. (B) Western blot assay used to directly detect the transient expression of scFvs (~30 KDa) in
serum-free cultured DF-1 cells. (C) Indirect-ELISA assay used to assess the titer of scFvs binding to HA protein. (D) IFA used to detect the virus
binding activity of scFvs. After infection by FJ13 virus (yellow) for 36 h, MDCK cells (red) were subjected to IFA using scFv1, scFv2, scFv3 and
monoclonal antibody against AIV H5N1 subtype HA protein as primary antibodies. The positive control used the 1:300 anti-AIV H5N1 HA mAb
and the negative used antibody diluent as the primary antibodies. (E) Virus neutralization of ScFvs, detected by IFA. The scFvs and anti-AIV H5N1
HA mAb (1:30, as the positive control) were incubated with FJ13 virus (200CCID50, yellow ) respectively for 1h before infection of MDCK cells
(red). The negative control used antibody diluent instead. Anti-AIV H5N1 HA mAb was used as the primary antibody. In (D) and (E), the cells were
counterstained with PI (red). Data are from 3 independent experiments (mean ± SD). Statistical significance was analyzed by Student’s t test;
*P <0.05; ** P <0.01; ns, not significant.
Figure 4 siRNA in combination with scFv1 against FJ13 virus in DF-1 cells. (A) Transient transfection of NP604 and DF-1 cells by pIRES2-scFv1.
The negative control was transfected by pIRES2-EGFP. (B) Expression of scFv1 in NP604 and DF-1 cells detected by western blot. (C) mRNA
levels of AIV FJ13 analyzed by qPCR from 24 h to 60 h p.i. in DF-1, NP604, scFv and scFv-NP604 cells. All measurements were normalized to
expression of β-actin genes, and the copies of HA gene mRNAs were quantified by comparison with a standard curve derived from known
amounts of pEASY-HA. (D) All cells were infected with 100 CCID50 of FJ13. Virus titers of supernatant samples collected at 60 h p.i. were
determined as CCID50 in normal MDCK cells. Data are from 3 independent experiments (mean ± SD). Statistical significance was analyzed by
Student’s t test; *P <0.05; **P <0.01; ns, not significant.
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pGADT7-ScFv (Figure 1A). Briefly, the pre-transformed
scFvs library in the AH109 yeast strain was mixed and
mated with Y187 containing pGBKT7-HA. After 24 h, the
culture was spread on SD/-Leu/-Trp plates and the surviv-
ing colonies were further verified on SD/-Leu/-Trp/-His/-
Ade medium. After 3 days, the colonies were streak cul-
tured on a new SD/-Leu/-Trp/-His/-Ade plate for 2 days.
A sterile filter paper was fitted closely over the plate which
had previously been dipped into Zbuffer/X-gal (Sino-
American, China). The positive clones gradually turned
blue between 30 min and 8 h.
Homology modeling and molecular docking
Both computational predictions were performed with Dis-
coveryStudio package with default settings. The template
for HA protein was 2IBX (sequence identity = 96%) [23].
While the template for the antibodies was 1AQK_H (se-
quence identity = 53%) [24]. The MODELLER module [25]
was used for homology modeling while the ZDOCK mod-
ule was used for the prediction of interactions between HA
protein and antibodies [26].
Cells transfection
Chicken DF-1 cells were stably transfected with the
shRNA_expression plasmid psiSTRIKE-NP604 (Target
sequence: AATGATCGGAATTTCTGGAGA) [15], using
Lipofectamine™ 2000 reagent (Invitrogen). The transfected
cells were selected with 800 μg/ml G418 (Merck) for 3
weeks with medium changed every 48 h. Individual col-
onies were picked and amplified in the same medium with
400 μg/ml G418. Transfectants expressing the shRNA
(NP604 cells) were maintained as cell lines.
ScFv1, scFv2 and scFv3 were cloned into the BglII and
EcoRI sites of bicistronic expression vector pIRES2-
EGFP (Clontech) to generate pIRES2-scFv1, pIRES2-
scFv2 and pIRES2-scFv3 respectively. DF-1 and NP604
cells were transiently transfected with the pIRES2-scFvs
using Lipofectamine™ 2000 according to the manufac-
turer’s instructions.
Western blotting
Following transfection, culture supernatants containing
scFvs were collected and concentrated in Millipore filter
tubes (Amicon-Ultra-15 MWCO 10KD). The primary
antibody was mouse anti-c-Myc Epitope Tag mAb
(MBL: 1:1000 dilution) and the method details have been
given previously [27].
Indirect-ELISA
FJ13 virus purified by polyethylene glycol (PEG) precipi-
tation was adjusted to a concentration of 5 μg/ml in
phosphate buffered saline (PBS, pH7). A total of 100 μl
per well was used for binding to 96 well plates overnightat 4°C. The three scFvs diluted to 1 μg/ml with antibody
diluent (PBST/ 0.1% BSA) were added to separate wells
as primary antibodies. Positive control wells consisted of
100 μl Anti-AIV H5N1 HA mAb (1:300; a gift from Pro-
fessor Sun Ming) as well as antibody diluent alone as a
negative control. Mouse anti-c-Myc Epitope tag mAb
(MBL) diluted 1:1000 was the secondary antibody, and
goat-anti-mouse IgG HRP (1:2000) (MBL) the third. The
method details have been given previously [15].
Indirect immunofluorescence assay
MDCK cells were washed 3 times with PBS and fixed in
cold fixative solution (acetone: methanol, 3:1) for 10 min
at 4°C followed by 3 washes with PBS and incubation for
1 h at 37°C with individual primary antibodies. The cells
were washed 3 times and incubated with purified pri-
mary mouse anti-c-Myc Epitope Tag mAb (MBL: 1:1000
dilution) as the second antibody. The cells were again
washed 3 times, incubated with fluorescein isothiocyan-
ate (FITC)-conjugated goat anti-mouse IgG antibody
(Sigma, 1:100 dilution) for 1 h at 37°C, washed a further
3 times with PBS, and stained with 100 μg/ml propidium
iodide (PI) for 5 min. Fluorescence was observed with a
confocal laser scanning microscope (Nikon TE2000-E).
Real-time quantitative PCR (qPCR) analysis
For quantitation of AIV replication in different cells
from 12 h to 60 h (sampling every 12 h) following infec-
tion with 100 CCID50 FJ13, total RNA was extracted
from 250 μl cell lysate supernatants using Trizol reagent
(Invitrogen), and qPCR reactions were performed using
Faststart SYBR Green mixture (with ROX; CWBIO) and
the Roche 480 real-time PCR detection system. Thermal
cycle conditions were initial denaturation at 94°C for 3
min, followed by 40 cycles at 94°C for 10 s, 60°C for 30
s, and melting curve at 95°C for 15 s and 60°C for 15 s.
The specific primers used for identification of the HA
gene were: 5′-GCCATTCCACAACATACACCCTC-3′
(sense) and 5′-TTCCCTGCCATCCTCCCTC-3′ (anti-
sense). Cellular β-actin gene was quantified as an internal
control. The copies of HA mRNAs were quantified by
comparison with a standard curve derived from known
amounts of pEASY-HA plasmid (Trans, China).
Highlights
1. We reported a novel combination of anti-AIV H5N1
siRNA and scFv.
2. Anti-AIV siRNA was expressed in the cells and scFv
was secreted from the cells.
3. This combination has a synergistic inhibitory effect
on virus proliferation.
4. Using bioinformatics software and Y2H for
screening scFvs reduced labor intensity.
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